Israel - hebreo - Ministry of Health

pfizer pharmaceuticals israel ltd - tigecycline - אבקה מיובשת בהקפאה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu

Israel - hebreo - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - אבקה להכנת תמיסה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu

Israel - hebreo - Ministry of Health

lapidot medical import and marketing ltd - metronidazole - תמיסה לאינפוזיה - metronidazole 500 mg / 100 ml - metronidazole - metronidazole - treatment and prophylaxis of infection which are or may be due to anerobic bacteria,especially bacteriodes species,including bacteriodes fragilis, fusobacterium,eurobacterium and clostridium species.

Israel - hebreo - Ministry of Health

lapidot medical import and marketing ltd - metronidazole - תמיסה לאינפוזיה - metronidazole 500 mg / 100 ml - metronidazole - metronidazole - treatment and prophylaxis of infection which are or may be due to anerobic bacteria,especially bacteriodes species,including bacteriodes fragilis, fusobacterium,eurobacterium and clostridium species.

Israel - hebreo - Ministry of Health

neopharm (israel) 1996 ltd - maralixibat chloride - תמיסה (פומי) - maralixibat chloride 10 mg/ml - maralixibat chloride

Israel - hebreo - Ministry of Health

medison pharma ltd - odevixibat as sesquihydrate - קפסולה קשיחה - odevixibat as sesquihydrate 1200 mcg - odevixibat

Israel - hebreo - Ministry of Health

medison pharma ltd - odevixibat as sesquihydrate - קפסולה קשיחה - odevixibat as sesquihydrate 200 mcg - odevixibat

Israel - hebreo - Ministry of Health

medison pharma ltd - odevixibat as sesquihydrate - קפסולה קשיחה - odevixibat as sesquihydrate 400 mcg - odevixibat

Israel - hebreo - Ministry of Health

medison pharma ltd - odevixibat as sesquihydrate - קפסולה קשיחה - odevixibat as sesquihydrate 600 mcg - odevixibat

Israel - hebreo - Ministry of Health

bayer israel ltd - hypericum perforatum - טבליות מצופות פילם - hypericum perforatum 612 mg - symptoms of mild to moderate depression. treatment is recommended for up to 12 weeks.